Objective: a (CAMK2A) and b (CAMK2B) isoforms of Calcium/calmodulindependent protein kinase II (CaMKII) play a pivotal role in neuronal plasticity and in learning and memory processes in the brain. Here, we explore the possible involvement of a-and b-CaMKII variants in neurodevelopmental disorders. Methods: Whole-exome sequencing was performed for 976 individuals with intellectual disability, developmental delay, and epilepsy. The effect of CAMK2A and CAMK2B variants on CaMKII structure and firing of neurons was evaluated by computational structural analysis, immunoblotting, and electrophysiological analysis. Results: We identified a total of five de novo CAMK2A and CAMK2B variants in three and two individuals, respectively. Seizures were common to three individuals with CAMK2A variants. Using a minigene splicing assay, we demonstrated that a splice site variant caused skipping of exon 11 leading to an in-frame deletion of the regulatory segment of CaMKIIa. By structural analysis, four missense variants are predicted to impair the interaction between the kinase domain and the regulatory segment responsible for the autoinhibition of its kinase activity. The Thr286/Thr287 phosphorylation as a result of release from autoinhibition was increased in three mutants when the mutants were stably expressed in Neuro-2a neuroblastoma cells. Expression of a CaMKIIa mutant in primary hippocampal neurons significantly increased Atype K + currents, which facilitated spike repolarization of single action potentials. Interpretation: Our data highlight the importance of CaMKIIa and CaMKIIb and their autoinhibitory regulation in human brain function, and suggest the enhancement of A-type K + currents as a possible pathophysiological basis.
Introduction
Calcium/calmodulin-dependent protein kinase II (CaM-KII) is a serine/threonine kinase that is highly abundant in brain, especially in the postsynaptic density (PSD). CaMKII forms a homomeric or heteromeric dodecamer of four different isoforms (a, b, c, d) encoded by four genes (CAMK2A, CAMK2B, CAMK2G, and CAMK2D, respectively), and a and b isoforms are predominant in the brain. 1, 2 In the resting state, the kinase activity of each subunit of CaMKII is inhibited by binding of the regulatory segment of CaMKII to the substrate binding groove of its kinase domain, which is called autoinhibition. [2] [3] [4] When Ca /CaM to the regulatory segment dissociates the segment from the kinase domain, and the following phosphorylation of Thr286/287 (Thr286 in CaMKIIa and Thr287 in CaMKIIb) within the regulatory segment by adjacent subunits prevents the segment back to the kinase domain. This produces the fully active, autophosphorylated form of CaMKII, whose activity persists even after the end of Ca 2+ rises. 2, 5, 6 This CaMKII activity is essential for neuronal plasticity and learning, [7] [8] [9] [10] [11] and its dysfunction has recently been implicated in neurpsychiatric disorders including schizophrenia, epilepsy and autism spectrum disorders. 1, 2, 6, 12 Phosphorylation by CaMKII can facilitate membrane localization of receptors and channels that are important for regulating neuronal excitability. 2, 10 Rapidly activating and inactivating A-type K + currents (I A ) are one of key determinants of neuronal excitability. I A plays a role in regulating action potential durations, repetitive firing rates, backpropagation of action potentials and in modulating synaptic transmission and plasticity. 13, 14 The voltage-gated K + (Kv) channel pore-forming (a) subunits responsible for I A include the Kv4 subfamily. [14] [15] [16] In hippocampal pyramidal neurons, the Kv4.2 subunit is highly expressed in dendrites, 17, 18 and its activity can be downregulated through phosphorylation by extracelluar-regulated kinase, protein kinase A and C. 14, 18, 19 By contrast, CaMKIImediated phosphorylation of Kv4.2 and Shal, the Drosophila homolog of mammalian Kv4, increases I A densities.
19,20
Here we report a total of five individuals with neurodevelopmental disorders, who harbor de novo variants in CAMK2A and CAMK2B that impair the autoinhibition of CaMKII. We propose the increase in I A density caused by the variants as a possible pathophysiological basis.
Materials and Methods

Subjects
All the five individuals were recruited in this study because of unexplained neurodevelopmental phenotypes. The total pool of recruitment consisted of 976 individuals with intellectual disability, developmental delay, and epilepsy. Most individuals (890 cases) were recruited as a cohort of infantile epilepsy who showed various degrees of intellectual disability and developmental delay. Remaining 86 cases were recruited as a cohort of cerebellar atrophy, and they also showed various degrees of intellectual disability and developmental delay. Clinical information and peripheral blood samples were obtained after written informed consent was provided. Experimental protocols were approved by the institutional review boards of Yokohama City University School of Medicine and Showa University School of Medicine.
Whole-exome sequencing
Genomic DNA was captured using SureSelect Human All Exon v4 or v5 (Agilent Technologies, Santa Clara, CA), and sequenced on an Illumina HiSeq2500 (Illumina, San Diego, CA) with 101 bp paired-end reads. Exome data processing, variant calling, and variant annotation were performed at Department of Human Genetics, Yokohama City University Graduate School of Medicine as described previously. 21 
Minigene construct and splicing analysis
A DNA fragment containing exons 10-12 along with introns 10 and 11 was amplified with polymerase chain reaction (PCR) using KOD-Plus Neo DNA polymerase (Toyobo, Osaka, Japan). Genomic DNA extracted from patient's lymphoblastoid cells was used as a template. The addition of restriction enzyme sites and alteration of first three bases of exon 10 to ATG codon were performed using following primers: 5 0 -CTCGAGATGCCATCGCCG GAATGGGACACT -3 0 and 5 0 -GGATCCCAGTTCCTGGT GGCCAGCATCGT -5 0 . A XhoI and BamHI digested DNA fragment was cloned into pEGFP-N1 vector (Takara Clontech, Otsu, Japan). Exonic sequences and 50-bp intronic sequences from exon-intron border were validated by Sanger sequencing. Two independent clones of each wild-type and mutant allele minigene construct (2.5 lg each) were transfected into Neuro-2a cells by Lipofectamine 2000 (Life technologies, Carlsbad, CA) for 24 hrs. Total RNA was extracted using RNeasy Plus Mini kit (Quiagen, Hilden, Germany), and 2 lg total RNA was subjected to reverse transcription using PrimeScript II 1st strand cDNA synthesis kit with random hexamers (Takara Bio, Otsu, Japan). One ll cDNA was used for 25 cycled PCR using KOD-FX Neo DNA polymerase (Toyobo). Primer sequences are 5 0 -CGGAAGCCAAGGATCTGA -3 0 in exon 10 of CAMK2A and 5 0 -GAACTTCAGGGTCA GCTTGC -3 0 in EGFP gene. For detecting heteroduplexed fragments, PCR products were digested with T7 Endonuclease I (New England Biolabs, Ipswich, MA). PCR products were electrophoresed in 3% agarose gel and visualized with Midori Green direct (Nippon Genetics, Tokyo, Japan) and FAS-Digi illuminator (Nippon Genetics). Experiments were repeated twice using independently collected samples. A-tailed PCR products were cloned into pGEM-T easy vector (Sigma, St. Louis, MO) and sequenced.
Expression vectors
A full-length human CAMK2A (pF1KA0968 that encodes NP_741960.1, 478aa) and CAMK2B (pF1KB8435 that encodes NP_742078.1, 503aa) cDNA clones were purchased from Kazusa DNA Research Institute (Chiba, Japan). Site-directed mutagenesis using a KOD-PlusMutagenesis kit (Toyobo, Osaka, Japan) was performed to generate CAMK2A and CAMK2B variants including c.635C>A (p.Pro212Gln) and c.704C>T (p.Pro235Leu) in CAMK2A, and c.638C>T (p.Pro213Leu) and c.852A>T (p.Arg284Ser) in CAMK2B. For establishing stable cell lines, wild-type and mutant CAMK2A cDNAs were cloned into pEF1a-EGFP vector, in which N-terminal EGFPtagged products and neomycin resistance gene are expressed. Wild-type and mutant CAMK2B cDNAs were cloned into pEF1a-mClover2 vector, in which N-terminal mClover2 (a variant of GFP) tagged products and hygromycin resistance gene are expressed. For expression in mouse primary hippocampal neurons, wild-type and p.Pro212Gln mutant of CAMK2A cDNAs were cloned into the pCIG vector 22 to simultaneously express nuclearlocalized EGFP for transfection monitoring.
Model selection for structural evaluations and calculation of free energy changes upon amino acid substitutions
We searched structure models for human CaMKIIa and b using Phyre2 23 and selected the two crystal structures: the low-resolution (3.55 A) crystal structure covering most part of the full-length human CaMKIIa (PDB code 3soa) and the high-resolution (2.3 A) one covering the kinase domain and the regulatory segment of human CaMKIIa (PDB code 2vz6). The FoldX calculation was performed using the latter crystal structure.
Cell culture and immunoblotting
The mouse Neuro-2a cell line were maintained at 37°C in 5% CO 2 in air in high glucose Dulbecco's Modified Eagle Medium containing 10% fetal bovine serum and penicillin-streptomycin. Electroporation to 1 9 10 6 cells was performed using a NEPA21 electroporator (NEPA GENE, Chiba, Japan) according to the manufacturer's instructions. EGFP-CAMK2A and mClover2-CAMK2B expressing cells were selected with 400 ng/lL neomycin and 600 ng/lL hygromyscin B, respectively. In addition, EGFP and mClover2 positive cells were sorted using a cell sorter (MoFlo Astrios, Beckman Coulter, Fullerton, CA). The cells were collected with 29 SDS sample buffer, and then analyzed by SDS-PAGE and immunoblotting using a rabbit anti-phospho-CaMKII (Thr286/Thr287) antibody (1/ 2000 dilution, D21E4, Cell signaling, Danvers, MA) and a mouse anti-GFP antibody conjugated with horseradish peroxidase (1/2000 dilution, B-2, Santa Cruz Biotechnology, Dallas, TX). Can get signal immunoreaction enhancer solution (TOYOBO, Osaka, Japan) was used for detection of phospho-CaMKII. The secondary antibody against the anti-phospho-CaMKII antibody was a goat anti-rabbit antibody conjugated with horseradish peroxidase (1/5000 dilution, Jackson immunoReserch, West Grove, PA). Blots were detected using the Clarity Western blot ECL substrate (BioRad, Hercules, CA) and the ChemiDoc Touch imaging system (BioRad). Quantification of band intensity was performed with ImageJ software (NIH, Bethesda, MD). The intensity of phospho-CaMKII was normalized to that of GFP, and the ratio was further normalized to the average of phospho-CaMKII/GFP signal ratios of EGFP-CAMK2A wild-type or mClover2-CAMK2B wild-type. Experiments were repeated three times, and statistical differences were assessed by ANOVA followed by Dunnett's post hoc test.
Electrophysiology
For electrophysiological analysis of CaMKII mutants, primary cultured hippocampal neurons were transfected with the expression vector described above. Neurons were prepared from the hippocampi of ICR mouse embryos on E16. Hippocampi were treated with TrypLE Express (Life technologies, Carlsbad, CA) enzyme solution at 37°C for 20 min, and then minced and triturated using a Pasteur pipette. Expression vectors were introduced into dissociated neurons by electroporation with an Amaxa Nucleofector device (Lonza), according to the manufacturer's protocol. Transfected neurons were seeded at a density of 1-1.5 9 10 5 cells per well onto poly-L-lysine-coated matrix sheets (Celltight PL Celldesk LF, MS-0113L; Sumitomo Bakelite, Tokyo, Japan) placed at the bottom of individual wells of 24-well plates, and incubated at 37°C in a humidified 5% CO 2 -95% air environment. The culture medium contained Neurobasal, B27 supplement, 0.5 mmol/L GlutaMAX-I, and 50 U and 50 lg/mL of penicillin-streptomycin (all from Life technologies). Osmolality of this culture medium was 220 mOsm/kg H 2 O. Experiments were performed after 18-22 days in vitro. Pyramidal-like neurons expressing nuclear-localized EGFP were selected under epifluorescent illumination.
Membrane voltages and currents in neurons were recorded using the whole-cell patch-clamp technique with an EPC10 amplifier controlled via Patchmaster software (HEKA Elektronik, Lambrecht, Germany). Records were filtered at 10 kHz and digitized at 50 kHz for voltage recordings and at 100 kHz for current recordings. Patch pipettes were fabricated from borosilicate glass capillaries using a P-97 puller (Sutter Instrument, Novato, CA All experiments were performed at 27-30°C.
Statistics
For electrophysiological data, statistical analysis was performed using IBM SPSS software. Data were first assessed for normality of distribution using the KolmogorovSmirnov test. When confirmed, multiple comparisons were performed using one-way ANOVA followed post hoc by Ryan-Einot-Gabriel-Welsch F (REGW-F) or Dunnett's T3 tests, depending if equal variances could be assumed or not, respectively, from Levene statistic. Statistical significance was defined as P < 0.05. Data are presented as mean AE SE of the mean (SEM).
Results
De novo CAMK2A and CAMK2B variants in individuals with neurodevelopmental disorders
By whole-exome sequencing (WES) study for approximately 1000 individuals with neurodevelopmental disorders, we found three CAMK2A and two CAMK2B Fig. 1) . Triobased WES identified de novo CAMK2A and CAMK2B variants in individuals 1 and 4, respectively. Subsequently, we searched for CAMK2A and CAMK2B variants in caseonly WES data, and found three individuals (individuals 2, 3, and 5).
CaMKIIa and CaMKIIb are highly similar in amino acid sequences of the kinase domain, the regulatory segment and the association domain, but are different in those of the linker region ( Fig. 1) . 2, 3 Four missense variants occurred at evolutionarily conserved amino acids in the kinase domain and the regulatory segment. All the variants were confirmed as de novo by Sanger sequencing, and were predicted to be damaging by Web-based prediction tools, and not found in ExAC (http://exac.broadinsti tute.org) and gnomAD database (http://gnomad.b roadinstitute.org/) (Table S1 ). Parentage was confirmed by microsatellite analysis as previously described. 24 We confirmed that c.817-1G>A causes skipping of exon 11 leading to in-frame deletion (p.His273_Lys300del) and other two minor abnormal splicing resulting in frameshift using minigene assay (Fig. 2 ) because the expression level of CAMK2A in lymphoblastoid cells was extremely low. Interestingly, exome data and Sanger sequencing indicated that the c.704C>T variant in individual 2 could be a somatic variant ( Fig. 1 and Table S2 ). We confirmed de novo somatic mosaicism of the c.704C>T variant by deep sequencing of PCR products amplified with blood, nail, and saliva DNA from individual 2 and blood DNA from her parents, showing that approximately 40-80% of cells harbored the variant (Table S2 ). Both CAMK2A and CAMK2B showed high Z score for missense variants in ExAC (5.2 and 3.5, respectively), suggesting that two genes are intolerant to variation. CAMK2A is also 
de novo Figure 1 . De novo CAMK2A and CAMK2B variants in individuals with neurodevelopmental disorders. Schematic representation of domain structures of CaMKIIa and CaMKIIb. About CaMKIIa, its isoform 2 (NP_741960.1), which differs from the isoform 1 (NP_057065.2) in length of linker region, is shown because this isoform has been well examined. 2 The numbers indicate the positions of amino acid residues. Thr286 in CaMKIIa and Thr287 in CaMKIIb are shown in red. All the missense variants occurred at evolutionarily conserved amino acids, and a splice site variant caused in-frame deletion of the regulatory segment including Thr286. All the variants were confirmed as de novo. Homologous sequences were aligned using the CLUSTALW web site (http://www.genome.jp/tools/clustalw/). . Two bands (white dots) were proven to be heteoduplexed products because these bands disappeared after T7 endonuclease digestion (right panel). Both mock transfected sample and minus reverse transcriptase control with no reverse transcriptase showed no detectable products. (C) Sequence of the PCR products revealed that three types of aberrant splicing were caused by the variant. Two would result in frameshift, and one leads to an in-frame deletion (p.His273_Lys300del). intolerant to loss-of-function variants (pLI = 1.0), but CAMK2B is less intolerant to loss-of-function variants (pLI = 0.47), suggesting that a simple loss-of-function scenario might be less likely in CAMK2B.
Phenotypes associated with CAMK2A and CAMK2B variants
Neurological features of five individuals with CAMK2A and CAMK2B variants are shown in Table 1 , and case reports are available in the Data S1. Initial symptoms were recognized within 4 months of age except for individual 4, and were seizures in three individuals with CAMK2A variants and developmental delay in two individuals with CAMK2B variants. Four individuals developed various types of seizures, which were intractable in two individuals. Individual 2 showed epileptic spasms and hypsarrhythmia on electroencephalogram (EEG) (Fig. 3) leading to the diagnosis of West syndrome. All four individuals with epileptic seizures showed focal or multifocal epileptic discharges on EEG (Fig. 3 ), but no other characteristic patterns were observed. Intellectual disability and developmental delay were profound in four individuals but mild in one (individual 4), in whom the onset of his first symptom was later than others. Abnormal movement or behavior such as myoclonus, stereotypic and hyperkinetic behaviors were observed in four individuals (see Video S1). Brain magnetic resonance imaging (MRI) showed normal findings at first in all individuals. However, progressive cerebellar atrophy in two individuals (Fig. 4 ) and acquired microcephaly with no structural abnormalities in three were observed later. These data suggest that CAMK2A and CAMK2B variants can cause variable neurodevelopmental phenotypes.
CAMK2A and CAMK2B variants affect autoinhibition of kinase activity and increase autophosphorylation of Thr286/287
The in-frame deletion (p.His273_Lys300del) by c.817-1G>A variant removes most of the regulatory segment that mediates autoinhibition of CaMKII. Thus it is possible that the p.His273_Lys300del mutant might exhibit constitutive activity. To evaluate the impact of the CAMK2A and CAMK2B missense variants on CaMKII structure, we mapped the variant sites on the crystal structures of human CaMKIIa in complex with an inhibitor bosutinib (PDB code 3soa) 25 and in complex with an inhibitor indirubin E804 (PDB code 2vz6) 26 and calculated the free energy changes upon the amino acid changes using the FoldX software. 27 The variant sites are located around the interaction surfaces between the kinase domain and the regulatory segment. Pro212 (note that the Pro212 in CaMKIIa corresponds to Pro213 in CaMKIIb) in the kinase domain is in a hydrophobic core formed with the regulatory segment (Fig. 5A) . Thus, the substitution of Pro212 with glutamine or leucine residue could destabilize the hydrophobic core and impair the interaction between the kinase domain and the regulatory segment, leading to a partial loss of autoinhibition of the CaMKII. The FoldX calculation, which indicated a significant increase in free energy change upon the Pro212Gln in CaMKIIa or Pro213Leu in CaMKIIb changes (Fig. 5A ), supports the above structural consideration. Pro235 in the kinase domain is involved in a b-turn, in which the main chain amide of Glu236 makes a hydrogen bond with the side chain of Arg284 in the regulatory segment (Fig. 5A) . Because a proline residue has distinct main chain geometry, the Pro235Leu substitution would affect the secondary structure and thereby impair the hydrogen bond between the main chain of Glu236 and the side chain of Arg284. The Arg284 side chain also makes a hydrogen bond with the side chain of Thr239 (Fig. 5A, the close-up) . Thus, the Pro235Leu and the Arg284Ser replacement could impair the one or two hydrogen bonds between the kinase domain and the regulatory segment, respectively, leading to a partial loss of autoinhibition of the kinase activity. The FoldX calculations indicate mild to moderate increases in free energy upon the amino acid changes, being consistent with our structural consideration.
To confirm the impaired interaction between the kinase domain and the regulatory segment of CaMKII predicted 
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by structural analysis, we generated Neuro-2a stable cell lines expressing wild-type or one of four missense mutants of GFP-tagged CaMKIIa and CaMKIIb. Immunoblot analysis showed that Thr286/Thr287 phosphorylation in three mutants was increased compared with that of wild-type, even without stimulation with Ca 2+ and Calmodulin (Fig. 5B) , though the degrees of increase in Pro235Leu and Pro213Leu mutants did not reach statistical significance (Fig. 5C) . No signals were observed in the Arg284Ser mutant of CaMKIIb, but it is possible that the Arg284Ser change abolished binding of antiphosphoThr286/Thr287 antibody. These data support the idea that four variants disrupt the interaction between the kinase domain and the regulatory segment, leading to decreased autoinhibition and increased Thr286/Thr287 autophosphorylation.
The Pro212Gln mutant of CaMKIIa upregulates I A in hippocampal neurons
Next, we examined whether the CaMKII mutants affect basic membrane properties and firing of neurons. To this end, we transfected primary hippocampal neurons with the vector encoding the Pro212Gln (P212Q) mutant, which showed a markedly enhanced basal autophosphorylation level, and compared the properties with those of the neurons transfected with empty vector or wild-type CaMKIIa vector, using the whole-cell patch-clamp technique.
A notable change was the faster downstroke of an action potential (AP) without a change in speed of upstroke in P212Q-expressing neurons (Fig. 6A and C) . This resulted in a significantly shorter half-width of an AP in these neurons (Fig. 6C) . In addition, the input resistance, which is the reciprocal of resting membrane conductance, was significantly reduced, and the minimum threshold current for AP generation, called rheobase, was increased in P212Q-expressing neurons (Fig. 6C) . The resting membrane potential, the threshold voltage level for AP generation and the AP amplitude were unchanged (data not shown). These suggested an enhancement of some voltage-dependent K + conductance in these neurons. When repetitive APs were elicited by a long current injection (Fig. 6B) , however, we noticed that only the downstroke of the 1st AP was facilitated, which caused the deeper 1st interspike voltage level in P212Q-expressing neurons (Fig. 6D) . In the following APs, downstrokes, interspike voltages and the rates of AP firing and adaptation were unchanged compared with empty vector-and wild-type CaMKIIa-expressing neurons (Fig. 6D) . This implied the disappearance of K + conductance enhancement in the following APs. Thus, some rapidly inactivating type of K + currents, like I A , would have been enhanced in P212Q-expressing neurons.
Voltage-clamp experiments confirmed that was indeed the case. I A can be extracted by applying a short 60 msec voltage pulse, during which I A is rapidly activated and then inactivated, before voltage steps to various levels (Fig. 7A ). Subtraction of current traces obtained with the prepulse protocol (Fig. 7A, right) from those obtained without the prepulse in the same neuron (Fig. 7A, left) thus revealed the voltage dependence of I A in the neuron (Fig 7A, below) . The current-voltage relationship of I A indicated significant increases in I A density in P212Q-expressing neurons (Fig. 7B, upper graph) . The voltage sensitivity of I A , estimated by fitting the relationship with the product of the Boltzmann equation and the Goldman-Hodgkin-Katz current equation, was unchanged (see legend of Fig. 7 for details) . The speed of inactivation was also not significantly different from those in empty vector-and wild-type CaMKIIa-expressing neurons (Fig. 7C) . Thus the P212Q mutant presumably increased the expression levels of I A -generating Kv channels without affecting their biophysical properties.
I A in hippocampal neurons can be produced at least by Kv4.2, Kv4.3, and Kv1.4.
14 Given the property of relatively rapid recovery of Kv4 channels from inactivation at low membrane voltage levels, 28 we further examined whether or not the Kv4-mediated component of I A was specifically enhanced in P212Q-expressing neuron by applying double voltage pulses at an interval of 100 msec. 29 Here we roughly estimated I A as the initial rapidly activating and inactivating component of the current evoked by a voltage pulse to À10 mV (Fig. 7D) . After the 100 msec interval, the second voltage pulse elicited I A with around 85% of the first I A amplitude (Fig. 7E ). Since Kv4 channels should have recovered from inactivation during the interval, most of the second I A must have been produced by Kv4 channels, and the remaining 15% of the first I A yet inactivated during the interval would have been produced by other I A -generating channels. We found that the ratio of the second to the first I A amplitudes was unchanged between all the three types of transfected neurons (Fig. 7E, rightmost graph) . Thus, in P212Q-expressing neurons, the expression of all types of I A -generating Kv channels would have been increased, although most of the I A was produced by Kv4 channels. Moreover, we also checked whether the basal level of miniature excitatory postsynaptic currents (mEPSCs) was altered in P212Q-expressing neurons. We did not see drastic changes in mEPSC amplitude (Fig. S1) , indicating that the increase in basal autophosphorylation level of the P212Q mutant did not greatly vary a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor densities in PSD.
Discussion
Recently, a de novo p.Glu183Val variant in CAMK2A has been reported in a patient with autism spectrum disorders. 12 The Glu183Val mutant decreased CaMKII substrate phosphorylation, and the Thr286 autophosphorylation of both heteromeric mutant and wild-type CaMKIIa was decreased, suggesting that the mutant acts in a dominant-negative manner. Expression of the Glu183Val mutant in hippocampal neurons disrupted dendritic morphology and synaptic transmission, highlighting that impaired CaMKIIa activity is linked to a neurodevelopmental phenotype. 12 In this study, we identified five de novo variants in CAMK2A and CAMK2B including four missense variants and one splice site variant leading to in-frame deletion that removed most of the regulatory segment. In contrast with the decreased autophosphorylation of the Glu183Val mutant, three of four missense mutants (Pro212Gln and Pro235Leu of CaMKIIa, and Pro213Leu of CaMKIIb) showed an increased autophosphorylation of Thr286/Thr287. In addition, although no signals of Thr287 phosphorylation was observed in the Arg284Ser mutant of CaMKIIb, a change in the Arg283 residue in CaMKIIa (Arg284 in CaMKIIb) to glutamic acid was proven to generate Ca 2+ -independent activity. 4 Therefore five variants identified in this study may cause a disturbance of CaMKII autoinhibition and an increased autophosphorylation of Thr286/287, thereby increasing its Ca 2+ -independent activity. Thus our data suggest that the basal increase in CaMKIIa activity is linked to neurodevelopmental disorders. Very recently, an international collaborative group has reported 18 de novo variants in CAMK2A or CAMK2B in 23 unrelated individuals with intellectual disability. 30 They found that several CAMK2A and CAMK2B variants showed decreased or increased CaMKII autophosphorylation at Thr286/Thr287, supporting the importance of CaMKII autophosphorylation in human brain function. 30 Because CaMKII is so abundant that it consists of 2-6% of total protein in the PSD 31 and essential for neuronal plasticity and learning, [7] [8] [9] [10] [11] it is plausible that CAMK2A and CAMK2B variants are associated with various neurodevelopmental phenotypes. It has been reported that the forebrain CaMKII dodecamer is comprised mostly of nine a and three b subunits, whereas this ratio is inverted in the cerebellar CaMKII. 32 In three individuals with CAMK2A variants, the initial symptoms were seizures, whereas in two individuals with CAMK2B variants, that was a developmental delay. Moreover, the individuals 4 and 5 with CAMK2B variants later developed episodic ataxia and progressive cerebellar atrophy, respectively. Thus the dysfunction of CaMKIIa seems to initiate seizures in the forebrain, whereas that of CaMKIIb seems to cause cerebellar symptoms. In the recent report, however, no apparent differences in seizure morbidity were observed between patients with CAMK2A and CAMK2B variants, and the morbidity of cerebellar symptoms is yet unknown. 30 Further accumulation of individuals with CAMK2A and CAMK2B variants will clarify phenotypic differences between CAMK2A and CAMK2B variants.
Expression of the Pro212Gln mutant of CaMKIIa in mouse hippocampal neurons increased I A . The CaMKII activity was reported to enhance the surface expression CaMKIIa. An overall view of the crystal structure of human CaMKIIa in complex with an inhibitor bosutinib (PDB code 3soa) and a close-up view of that in complex with an inhibitor indirubin E804 (PDB code 2vz6) are shown. The kinase domain, regulatory segment, linker region and association domain are colored wheat, pale green, pale blue and gray, respectively. The kinase inhibitor bosutinib is depicted as gray sticks. Residues at the variant sites are displayed as red spheres or sticks. In the close-up view of the white rectangular region, the side chains involved in a hydrophobic core with the mutated proline residues are shown as van der Waals spheres. Ca 2+ /calmodulin-dependent autophosphorylation site (Thr286 of CaMKIIa) is indicated as orange spheres. Black dotted lines represent hydrogen bonds. The bar graph below shows free energy changes upon the amino acid changes predicted by the FoldX software. 27 Colors of the bars correspond to the mutated molecular areas. The
FoldX calculation was performed using the crystal structure of human CaMKIIa (PDB code 2vz6). (B) Immunoblot analysis using an antiphosphoThr286/Thr287 CaMKII antibody (p-CaMKII) and an anti-GFP antibody (GFP) with Neuro-2a cells expressing EGFP-tagged CAMK2A (EGFP-CAMK2A wild-type, Pro212Gln, and Pro235Leu) and mClover2-tagged CAMK2B (mClover2-CAMK2B wild-type, Pro213Leu and Arg284Ser 29 The dendritic I A limits AP backpropagation into dendrites, thereby restricting postsynaptic depolarization required for the long-term potentiation of excitatory synapses. 29, 33 Therefore, it is likely that the neurodevelopmental sequelae in our patients might have been due, in part, to the sustained low efficiency of excitatory synaptic transmission caused by increased I A in the dendrites. Moreover, it is interesting to note that a de novo missense variant of KCND2 encoding Kv4.2, which was found in identical twins with autism and severe intractable epilepsy, slows I A inactivation and that this effect is dominant over the wild-type Kv4.2. 34 The slower inactivation should prolong the efficacy of I A. Thus the previous report and our results strongly suggest that the enhancement of I A would also produce epileptic phenotypes.
In conclusion, de novo variants in CAMK2A and CAMK2B were identified in five individuals with neurodevelopmental disorders. Our data highlight the importance of CaMKIIa and CaMKIIb and their autoinhibitory regulation in human brain function. 
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